Cellular perspectives on the glutamate-monoamine interactions in limbic lobe structures and their relevance for some psychiatric disorders

Progress in Neurobiology

Volumn 67, Issue 3, 2002, Pages 173-202

  Pralong, Etienne ^a   Magistretti, Pierre ^b   Stoop, Ron ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CATECHOLAMINE; DIZOCILPINE; DOPAMINE; DOPAMINE RECEPTOR; FLUOXETINE; GABAPENTIN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; HORMONE RECEPTOR; LAMOTRIGINE; LITHIUM; MONOAMINE; NORADRENALIN; PHENCYCLIDINE; SEROTONIN; SEROTONIN RECEPTOR; STABILIZING AGENT; TOPIRAMATE; VALPROIC ACID;

ADDICTION; AFFECTIVE NEUROSIS; AMYGDALOID NUCLEUS; CELL INTERACTION; DEPRESSION; ENTORHINAL CORTEX; EXCITATORY POSTSYNAPTIC POTENTIAL; GENETICS; HIPPOCAMPUS; HUMAN; LIMBIC SYSTEM; MANIA; MENTAL DISEASE; MOOD; NEUROANATOMY; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; REWARD; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

BIPOLAR DISORDER; BRAIN; DEPRESSIVE DISORDER; DOPAMINE; GLUTAMIC ACID; HUMANS; LIMBIC SYSTEM; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; SEROTONIN;

EID: 0036343122     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(02)00017-5     Document Type: Review

References (391)

1. D1 dopamine receptor activation reduces extracellular glutamate and GABA concentrations in the medial prefrontal cortex
2. The NMDA antagonist model for schizophrenia: Promise and pitfalls
3. Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus
4. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions
5. Facilitation of neocortical kindling by depletion of forebrain noradrenaline
6. Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder
7. Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro
8. A G protein couples serotonin and GABAB receptors to the same channels in hippocampus
9. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists
10. Noradrenergic modulation transmission between the entorhinal cortex and the dentate gyrus of the rat (proceedings)
11. Neuropharmacological mechanisms of drug reward: Beyond dopamine in the nucleus accumbens
12. Sensitivity to ageing of the limbic dopaminergic system: A review
13. Identification and characterisation of 5-hydroxytryptamine 3 recognition sites in human brain tissue
14. Hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine
15. Dopamine depresses excitatory synaptic transmission onto rat subicular neurons via presynaptic D1-like dopamine receptors
16. Dopamine evoked inhibition of single cells of the feline putamen and basolateral amygdala
17. Dopamine action on hippocampal pyramidal cells
18. Tryptophan depletion in stable lithium-treated patients with bipolar disorder in remission
19. Characterization of subtype-specific antibodies to the human D5 dopamine receptor: Studies in primate brain and transfected mammalian cells
20. Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain
21. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience?
22. Alpha 2-adrenergic agonists reduce glutamate release and glutamate receptor-mediated calcium changes in hippocampal slices during hypoxia
23. Effects of serotonin through serotonin1A and serotonin4 receptors on inhibition in the guinea-pig dentate gyrus in vitro
24. Imipramine increases the 5-HT1A receptor-mediated inhibition of hippocampal neurons without changing the 5-HT1A receptor binding
25. Dopamine D(1) agonist activates temporal lobe structures in primates
26. The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey
27. Current advances and trends in the treatment of depression (see comments)
28. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins
29. A synaptic model of memory: Long-term potentiation in the hippocampus
30. The central 5-HT3 receptor in CNS disorders
31. The D1 dopamine receptor agonist SKF-38393 stimulates the release of glutamate in the hippocampus
32. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: Comparison with dopamine D2 receptor mRNA
33. LTP in the lateral perforant path is beta-adrenergic receptor-dependent
34. Cognition and control in schizophrenia: A computational model of dopamine and prefrontal function
35. Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats
36. Anatomie comparée des circonvolutions cérébrales. Le grand lobe limbique et la scissure dans la série des mammifères
37. Increased extracellular release of hippocampal NE is associated with tetanization of the medial perforant pathway in the freely moving adult male rat
38. Hippocampal remodeling and damage by corticosteroids: Implications for mood disorders
39. Release of dopamine in the nucleus accumbens caused by stimulation of the subiculum in freely moving rats
40. Schizophrenia and the brain: A prospective clinico-neuropathological study
41. A second generation catecholamine hypothesis
42. International Union of Pharmacology nomenclature of adrenoceptors
43. Stress, depression and the mesolimbic dopamine system
44. Voltage-dependent neuromodulation of Na+ channels by D1-like dopamine receptors in rat hippocampal neurons
45. Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex
46. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinson's disease
47. Projections from the rat prefrontal cortex to the ventral tegmental area: Target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons
48. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: Clinical and theoretical implications
49. Direct inhibition of the N-methyl-D-aspartate receptor channel by dopamine and (+)-SKF38393
50. Serotonin depresses excitatory synaptic transmission and depolarization-evoked Ca2+ influx in rat basolateral amygdala via 5-HT1A receptors
51. Modulation by dopamine D1-like receptors of synaptic transmission and NMDA receptors in rat nucleus accumbens is attenuated by the protein kinase C inhibitor Ro 32-0432
52. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice
53. Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin
54. Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin
55. A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders
56. Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices
57. The glutamatergic dysfunction hypothesis for schizophrenia
58. Genetics of bipolar disorder
59. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene
60. Limbic/mesolimbic connections and the pathogenesis of schizophrenia
61. Induction of long-lasting potentiation by sequenced applications of isoproterenol
62. Localization of monoamines in the lower brain stem
63. Hippocampal and cortical sensory gating in rats: Effects of quinpirole microinjections in nucleus accumbens core and shell
64. Hippocampal and cortical sensory gating in rats: Effects of quinpirole microinjections in nucleus accumbens core and shell
65. A two-process theory of schizophrenia: Evidence from studies in post-mortem brain
66. Concurrent muscarinic and beta-adrenergic blockade in rats impairs place-learning in a water maze and retention of inhibitory avoidance
67. Dopamine action in the nucleus accumbens
68. Rapid serotonin depletion as a provocative challenge test for patients with major depression: Relevance to antidepressant action and the neurobiology of depression
69. Primate models of movement disorders of basal ganglia origin
70. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: The effects of water depth
71. The regulation of subcortical dopamine systems by the prefrontal cortex: Interactions of central dopamine systems and the pathogenesis of schizophrenia
72. Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: Implications for schizophrenia and Parkinson's disease
73. Effects of D2 dopamine receptor antagonists on Fos protein expression in the striatal complex and entorhinal cortex of the nonhuman primate
74. Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats
75. Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: Studies with transcerebral dialysis in freely moving rats
76. Functions of dopamine in the extrapyramidal and limbic systems. Clues for the mechanism of drug actions
77. Schizophrenia: Glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
78. Depression, mania and related disorders
79. Subgenual prefrontal cortex abnormalities in mood disorders
80. Neuroimaging abnormalities in the subgenual prefrontal cortex: Implications for the pathophysiology of familial mood disorders
81. MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens
82. Central 5-HT4 receptors
83. Facilitation of amygdala kindling in the rat by transecting ascending noradrenergic pathways
84. Mivazerol, a novel alpha2-agonist and potential anti-ischemic drug, inhibits KC1-stimulated neurotransmitter release in rat nervous tissue preparations
85. Anticipation in unipolar affective disorder
86. Genome scan of European-American schizophrenia pedigrees: Results of the NIMH Genetics Initiative and Millennium Consortium
87. Major depressive disorder
88. Anticonvulsant activity of the noradrenergic locus coeruleus system: Role of beta mediation
89. Clenbuterol administration into the basolateral amygdala post-training enhances retention in an inhibitory avoidance task
90. High potency of the orally-active NMDA-receptor antagonist CGP 40 116 in inhibiting excitatory postsynaptic potentials of rat basolateral amygdala neurones in vitro
91. Noradrenaline modulates glutamate-mediated neurotransmission in the rat basolateral amygdala in vitro
92. Basolateral amygdala noradrenergic influences on memory storage are mediated by an interaction between beta and alpha1 adrenoreceptors
93. Role of norepinephrine in mediating stress hormone regulation of long-term memory storage: A critical involvement of the amygdala
94. Dopamine D2 receptor gene (DRD2) haplotypes in Caucasians
95. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs
96. Basolateral amygdala stimulation evokes glutamate receptor-dependent dopamine efflux in the nucleus accumbens of the anaesthetized rat
97. Dopamine D1 and NMDA receptors mediate potentiation of basolateral amygdala-evoked firing of nucleus accumbens neurons
98. Modulation of hippocampal and amygdalar-evoked activity of nucleus accumbens neurons by dopamine: Cellular mechanisms of input selection
99. Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons
100. Nucleus locus ceruleus: New evidence of anatomical and physiological specificity
101. Opiate and alpha 2-adrenoceptor responses of rat amygdaloid neurons: Co-localization and interactions during withdrawal
102. Serotonergic control of the hippocampus via local inhibitory interneurons
103. Reinforcement of early long-term potentiation (early-LTP) in dentate gyrus by stimulation of the basolateral amygdala: Heterosynaptic induction mechanisms of late-LTP
104. Increased dopamine release in the human amygdala during performance of cognitive tasks
105. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways
106. Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits
107. Effects of anxiety and memory of systemic and intra-amygdala injection of 5-HT3 receptor antagonist BRL 46470A
108. Stimulation of 5-HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats
109. Fenfluramine blocks low-Mg2+-induced epileptiform activity in rat entorhinal cortex
110. Transmitter dysfunction during the process of schizophrenia
111. Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex
112. D(1) receptors in prefrontal cells and circuits
113. Dopamine inhibition of evoked IPSCs in rat prefrontal cortex
114. Dopamine D1/D5 receptor activation modulates a persistent sodium current in rat prefrontal cortical neurons in vitro
115. Serotonin and hippocampal neurogenesis
116. Gating of information flow within the limbic system and the pathophysiology of schizophrenia
117. Catecholamines in the central nervous system
118. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex
119. Noradrenaline and beta-adrenoceptor agonists increase activity of voltage-dependent calcium channels in hippocampal neurons
120. Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate
121. Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat
122. Dopamine decreases the excitability of layer V pyramidal cells in the rat prefrontal cortex
123. Multiple effects of dopamine on layer V pyramidal cell excitability in rat prefrontal cortex
124. Integrity of the mesocortical dopaminergic system is necessary for complete expression of in vivo hippocampal-prefrontal cortex long-term potentiation
125. Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo
126. The neuropathology of schizophrenia. A critical review of the data and their interpretation
127. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia
128. Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation
129. A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release
130. Norepinephrine infused into the basolateral amygdala posttraining enhances retention in a spatial water maze task
131. Piecing together the puzzle of basal forebrain anatomy
132. Basal Ganglia
133. Dopamine increases excitability of pyramidal neurons in primate prefrontal cortex
134. International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: Consensus update
135. Modulation of ion-channel function by G-protein-coupled receptors
136. Ueber die sympathicomimetische Wirksamheit von Gehirnextgrackten
137. The role of mesoaccumbens-pallidal circuitry in novelty-induced behavioral activation
138. Frequency-dependent noradrenergic modulation of long-term potentiation in the hippocampus
139. Glutamate receptor-dependent modulation of dopamine efflux in the nucleus accumbens by basolateral, but not central, nucleus of the amygdala in rats
140. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
141. Characterization of dopamine receptors mediating inhibition of excitatory synaptic transmission in the rat hippocampal slice
142. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus
143. Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus
144. Isoproterenol potentiates synaptic transmission primarily by enhancing presynaptic calcium influx via P- and/or Q-type calcium channels in the rat
145. Potentiation of N-methyl-D-aspartate currents by isoproterenol in the acutely dissociated rat amygdalar neurons
146. Selective enhancement of P-type calcium currents by isoproterenol in the rat amygdala
147. Norepinephrine promotes long-term potentiation in the adult rat hippocampus in vitro
148. Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex
149. Stimulation of prefrontal cortex at physiologically relevant frequencies inhibits dopamine release in the nucleus accumbens
150. A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine
151. Recent advances in the phencyclidine model of schizophrenia
152. Input from the amygdala to the rat nucleus accumbens: Its relationship with tyrosine hydroxylase immunoreactivity and identified neurons
153. Cerebral ventricular size and cognitive impairment in chronic schizophrenia
154. Searching for susceptibility genes in schizophrenia
155. Presynaptic inhibition by clonidine of neurotransmitter amino acid release in various brain regions
156. Distribution and functional properties of 5-HT3 receptors in the rat hippocampal dentate gyrus: A patch-clamp study
157. A review of functional neuroimaging in mood disorders: Positron emission tomography and depression
158. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem
159. Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats
160. Clinical experience with iproniazid (Marsilid)
161. Limbic-prefrontal connectivity and clozapine
162. Muscarinic and beta-adrenergic depression of the slow Ca2(+)-activated potassium conductance in hippocampal CA3 pyramidal cells is not mediated by a reduction of depolarization-induced cytosolic Ca2+ transients
163. Seizure suppression in kindling epilepsy by intracerebral implants of GABA - But not by noradrenaline-releasing polymer matrices
164. Neuropharmacology of cocaine and ethanol dependence
165. Role for the mesocortical dopamine system in the motivating effects of cocaine
166. Drug addiction: The yin and yang of hedonic homeostasis
167. Hedonic valence, dopamine and motivation
168. The role of the striatopallidal and extended amygdala systems in drug addiction
169. The serotoninergic innervation of cerebral cortex: Different classes of axon terminals arise from dorsal and median raphe nuclei
170. Glutamatergic hypothesis of schizophrenia: Psychoses induced by phencyclidine and cortical-subcortical imbalance
171. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, perceptual, cognitive, and neuroendocrine responses
172. Depotentiation in the dentate gyrus of freely moving rats is modulated by D1/D5 dopamine receptors
173. Serotonin transporter gene polymorphisms: Ethnic difference and possible association with bipolar affective disorder
174. Un nouveau stabilisateur végétatif (le 4560RP)
175. The action of norepinephrine in the dentate gyrus: Beta-mediated facilitation of evoked potentials in vitro
176. Intracellular responses of rat hippocampal granule cells in vitro to discrete applications of norepinephrine
177. The effects of ibotenic acid lesions of the medial and lateral prefrontal cortex on latent inhibition, prepulse inhibition and amphetamine-induced hyperlocomotion, prepulse inhibition and amphetamine-induced hyperlocomotion
178. Plasticity at hippocampal to prefrontal cortex synapses: Dual roles in working memory and consolidation
179. Stimulation of D1-type dopamine receptors enhances excitability in prefrontal cortical pyramidal neurons in a state-dependent manner
180. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies
181. Alpha2A-adrenergic receptors in the rat nucleus locus coeruleus: Subcellular localization in catecholaminergic dendrites, astrocytes, and presynaptic axon terminals
182. Ultrastructural evidence for prominent postsynaptic localization of alpha2C-adrenergic receptors in catecholaminergic dendrites in the rat nucleus locus coeruleus
183. Injections of N-methyl-D-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens
184. Chemical stimulation of the ventral hippocampus elevates nucleus accumbens dopamine by activating dopaminergic neurons of the ventral tegmental area
185. Lithium and the brain: A psychopharmacological strategy to a molecular basis for manic depressive illness
186. Serotonin and kindling development
187. Primary structure of the serotonin transporter in unipolar depression and bipolar disorder
188. Serotonin 5-HT1A receptors modulate hippocampal reactivity to afferent stimulation
189. D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons
190. Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamine uptake blockers
191. Distribution of dopaminergic receptors in the primate cerebral cortex: Quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390
192. Suggestive evidence for linkage of schizophrenia to markers on chromosome 13q14.1-q32
193. Modulation of voltage-dependent calcium currents by serotonin in acutely isolated rat amygdala neurons
194. The medial prefrontal cortex plays an important role in the excitation of A10 dopaminergic neurons following intravenous muscimol administration
195. Anatomic organization and physiology of the limbic cortex
196. Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation
197. Noradrenaline modulates the release of [14C]glutamate from dentate but not from CA1/CA3 slices of rat hippocampus
198. The hyperpolarization-activated current (Ih) and its contribution to pacemaker activity in rat CA1 hippocampal stratum oriens-alveus interneurones
199. Some psychiatric implications of physiological studies on the frontotemporal portion of the limbic system
200. Noradrenaline blocks accommodation of pyramidal cell discharge in the hippocampus
201. Actions of noradrenaline recorded intracellularly in rat hippocampal CA1 pyramidal neurones, in vitro
202. Acute tolerance to the dopamine response induced by a binge pattern of cocaine administration in male rats: An in vivo microdialysis study
203. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
204. Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: Molecular transduction of mood stabilization in the treatment of manic-depressive illness
205. The cellular neurobiology of depression
206. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens
207. Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo
208. D1/D5 dopamine receptor activation differentially modulates rapidly inactivating and persistent sodium currents in prefrontal cortex pyramidal neurons
209. Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones
210. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones
211. Stress and hippocampal plasticity
212. Suppression of amygdala kindling with massed stimulation: Effect of noradrenaline antagonists
213. Hippocampal interneurons are excited via serotonin-gated ion channels
214. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression
215. Hippocampal alpha2a-adrenergic receptors are located predominantly presynaptically but are also found postsynaptically and in selective astrocytes
216. Analysis of complex brain disorders with gene expression microarrays: Schizophrenia as a disease of the synapse
217. Dopamine receptors: From structure to function
218. Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit
219. Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit
220. Selective inhibition of local excitatory synaptic transmission by serotonin through an unconventional receptor in the CA1 region of rat hippocampus
221. Locomotor activity initiated by microinfusions of picrotoxin into the ventral tegmental area
222. From motivation to action: Functional interface between the limbic system and the motor system
223. Influence of dopamine on limbic inputs to the nucleus accumbens
224. The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon
225. The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus
226. Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous system
227. Reciprocal dopamine-glutamate modulation of release in the basal ganglia
228. Noradrenergic responses in rat hippocampus: Evidence for medication by alpha and beta receptors in the in vitro slice
229. Electrophysiology of the hippocampal and amygdaloid projections to the nucleus accumbens of the rat: Convergence, segregation, and interaction of inputs
230. Lithium and the phosphoinositide cycle: An example of uncompetitive inhibition and its pharmacological consequences
231. Disruption of phosphoinositide signalling by lithium
232. A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression
233. Ethanol, like psychostimulants and morphine, causes long-lasting hyperreactivity of dopamine and acetylcholine neurons of rat nucleus accumbens: Possible role in behavioural sensitization, causes long-lasting hyperreactivity of dopamine and acetylcholine neurons of rat nucleus accumbens: Possible role in behavioural sensitization
234. Genes and addiction
235. Molecular and cellular basis of addiction
236. Drug addiction: A model for the molecular basis of neural plasticity
237. Psychostimulants depress excitatory synaptic transmission in the nucleus accumbens via presynaptic D1-like dopamine receptors
238. Cortical gyral anatomy and gross brain dimensions in monozygotic twins discordant for schizophrenia
239. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims
240. Modulation of cell firing in the nucleus accumbens
241. A magnetic resonance imaging study in first-episode disorganized-type patients with schizophrenia
242. 5-HT1A receptor linked to inward-rectifying potassium current in hippocampal CA3 pyramidal cells
243. Positive reinforcement produced by electrical stimulation of septal area and other region of the rat brain
244. Glutamate receptor dysfunction and schizophrenia
245. Brain lesions in an infant rhesus monkey treated with monsodium glutamate
246. The chemical nature of the main central excitatory transmitter: A critical appraisal based upon release studies and synaptic vesicle localization
247. Dopamine facilitates long-term depression of glutamatergic transmission in rat prefrontal cortex
248. Dopamine receptors and groups I and II mGluRs cooperate for long-term depression induction in rat prefrontal cortex through converging postsynaptic activation of MAP kinases
249. Brain functions and psychiatric disorders. A clinical view
250. D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses
251. Dopamine selectively inhibits the direct cortical pathway to the CA1 hippocampal region
252. Dopamine, serotonin, and noradrenaline strongly inhibit the direct perforant path-CA1 synaptic input, but have little effect on the Schaffer collateral input
253. Glutamate receptors in the mammalian central nervous system
254. A proposed mechanism of emotion
255. PKA mediates the effects of monoamine transmitters on the K+ current underlying the slow spike frequency adaptation in hippocampal neurons
256. Dopamine modulates the slow Ca(2+)-activated K+ current IAHP via cyclic AMP-dependent protein kinase in hippocampal neurons
257. Pathway specificity of noradrenergic plasticity in the dentate gyrus
258. Presynaptic dopamine D1 receptors attenuate excitatory and inhibitory limbic inputs to the shell region of the rat nucleus accumbens studied in vitro
259. Neuroimaging studies of schizophrenia
260. Common neural substrates for the addictive properties of nicotine and cocaine
261. Transient and long-lasting actions of 5-HT on rat dentate gyrus neurones in vitro
262. N-methyl-D-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH and protein kinase C inhibition
263. Evidence implicating alpha-2 adrenergic receptors in the anticonvulsant action of intranigral muscimol
264. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens
265. Depression: A new animal model sensitive to antidepressant treatments
266. "Behavioural despair" in rats and mice: Strain differences and the effects of imipramine
267. A critical review of genetic studies of schizophrenia. II. Molecular genetic studies
268. A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures
269. Alterations in motor activity, sleep, and biochemistry in a cycling manic-depressive patient
270. Interactions of dopamine with glutamate- and GABA-mediated synaptic transmission in the rat entorhinal cortex in vitro
271. Noradrenaline reduces synaptic responses in normal and tottering mouse entorhinal cortex via alpha 2 receptors
272. Noradrenaline increases K-conductance and reduces glutamatergic transmission in the mouse entorhinal cortex by activation of alpha 2-adrenoreceptors
273. Potassium channels activated by GABAB agonists and serotonin in cultured hippocampal neurons
274. Three cases of manic symptoms following yohimbine administration
275. Modulation of locomotor activity by NMDA receptors in the nucleus accumbens core and shell regions of the rat
276. Serotonergic modulation of neurotransmission in the rat basolateral amygdala
277. Beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase
278. Long-term depression in the basolateral amygdala of the mouse involves the activation of interneurons
279. Association studies of bipolar disorder at the human serotonin transporter gene (hSERT 5HTT)
280. Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers
281. D2 dopaminergic receptor activation enhances the spontaneous release of 3H-GABA in the prefrontal cortex of rats, in vitro. The facilitating role of D1 dopaminergic receptors)
282. Opposing effects of dopamine D2 receptor stimulation on the spontaneous and the electrically evoked release of [3H]GABA on rat prefrontal cortex slices
283. Effects of 5-HT3 receptor antagonism on hippocampal cellular activity in the freely moving rat
284. Raphe grafts in the hippocampus, but not in the entorhinal cortex, reverse hippocampal hyperexcitability of serotonin-depleted rats and restore their responsiveness to fenfluramine
285. Neurobehavioural mechanisms of reward and motivation
286. Schizophrenia
287. Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine
288. Inhibitory action of serotonin in CA1 hippocampal neurons in vitro
289. Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo
290. Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats
291. Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo
292. Effects of noradrenaline on some potassium currents in CA1 neurones in rat hippocampal slices
293. Serotonin inhibits epileptiform discharge by activation of 5-HT1A receptors in CA1 pyramidal neurons
294. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders
295. Presynaptic inhibition of excitatory synaptic transmission mediated by alpha adrenergic receptors in area CA3 of the rat hippocampus in vitro
296. Nicotine and food induced dopamine release in the nucleus accumbens of the rat: Putative role of alpha7 nicotinic receptors in the ventral tegmental area
297. Additional support for schizophrenia linkage on chromosomes 6 and 8: A multicenter study
298. Serotonin reduces synaptic excitation of principal cells in the superficial layers of rat hippocampal-entorhinal cortex combined slices
299. Serotonin and 8-OH-DPAT reduce excitatory transmission in rat hippocampal area CA1 via reduction in presumed presynaptic Ca2+ entry
300. Serotonin blocks different patterns of low Mg2+-induced epileptiform activity in rat entorhinal cortex, but not hippocampus
301. Serotonin reduces synaptic excitation in the superficial medial entorhinal cortex of the rat via a presynaptic mechanism
302. Comparison of the effects of serotonin in the hippocampus and the entorhinal cortex
303. Serotonin reduces polysynaptic inhibition via 5-HT1A receptors in the superficial entorhinal cortex
304. Differential amygdala activation in schizophrenia during sadness
305. Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons
306. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons
307. Dopamine receptor pharmacology
308. Involvement of NMDA and AMPA/kainate receptors in the effects of endogenous glutamate on extracellular concentrations of dopamine and GABA in the nucleus accumbens of the awake rat
309. Molecular mechanisms of drug reinforcement and addiction
310. Mood-stabilizing drugs in depression
311. The alpha 2 adrenoreceptor agonist clonidine suppresses seizures, whereas the alpha 2 adrenoreceptor antagonist idazoxan promotes seizures: Pontine microinfusion studies of amygdala-kindled kittens
312. Monoamines and seizures: Microdialysis findings in locus ceruleus and amygdala before and during amygdala kindling
313. Excitatory and inhibitory action of dopamine on hippocampal neurons in vitro. Involvement of D2 and D1 receptors
314. Ethanol enhances the calcium-dependent stimulus-induced release of endogenous dopamine from slices of rat striatum and nucleus accumbens in vitro
315. Neurotransmitter activation of inwardly rectifying potassium current in dissociated hippocampal CA3 neurons: Interactions among multiple receptors
316. Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats
317. Decreased sensitivity of neurons in the basolateral amygdala to dopamine and noradrenaline iontophoresis after a kindling stimulus
318. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update
319. Molecular biology of schizophrenia
320. Serotonergic mechanism in seizures kindled from the rabbit amygdala
321. Noradrenergic modulation of epileptiform bursting and synaptic plasticity in the dentate gyrus
322. Blockade of norepinephrine-induced long-lasting potentiation in the hippocampal dentate gyrus by an inhibitor of protein synthesis
323. Noradrenergic modulation of excitability in acute and chronic model epilepsies
324. Dopamine modulates CA1 hippocampal neurons by elevating the threshold for spike generation: An in vitro study
325. Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat
326. Quantitative study of gliosis in schizophrenia and Huntington's chorea
327. Modulation of epileptiform discharges in the rat limbic system in vitro by noradrenergic agents
328. Activation of serotonergic 5-HT1A receptor reduces Ca(2+)- and glutamatergic receptor-evoked arachidonic acid and No/cGMP release in adult hippocampus
329. GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: A mechanism for modulation of sensory inputs related to fear conditioning
330. Serotonin modulation of sensory inputs to the lateral amygdala: Dependency on corticosterone
331. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia
332. 5-Hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala
333. Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice
334. Lithium distribution in mania: Plasma and red blood cell lithium, clinical state, and monoamine metabolites during lithium treatment
335. A double dissociation within the hippocampus of dopamine D1/D5 receptor and beta-adrenergic receptor contributions to the persistence of long-term potentiation
336. Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striato-pallido-thalamic function
337. GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats
338. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: Modulation by metabotropic glutamate receptors
339. Hyperlocomotion and increased dopamine efflux in the rat nucleus accumbens evoked by electrical stimulation of the ventral subiculum: Role of ionotropic glutamate and dopamine D1 receptors
340. Target-specific glutamatergic regulation of dopamine neurons in the ventral tegmental area
341. Glutamatergic aspects of schizophrenia
342. Hippocampo-prefrontal cortex pathway: Anatomical and electrophysiological characteristics
343. Activity-dependent beta-adrenergic modulation of low frequency stimulation induced LTP in the hippocampal CA1 region
344. Antidepressant-induced adaptive changes in the effects of 5-HT, 5-HT1A and 5-HT4 agonists on the population spike recorded in hippocampal CA1 cells do not involve presynaptic effects on excitatory synaptic transmission
345. Anatomy of the serotonergic system
346. Schizophrenia: Genes and environment
347. Glycogen phosphorylase activation by two different alpha 1-adrenergic receptor subtypes: Methoxamine selectively stimulates a putative alpha 1-adrenergic receptor subtype (alpha 1a) that couples with Ca2+ influx
348. Serotonin-operated potassium current in CA1 neurons dissociated from rat hippocampus
349. Multiple serotonin receptors: Too many, not enough, or just the right number?
350. GABA(B) receptors in the median raphe nucleus: Distribution and role in the serotonergic control of hippocampal activity
351. Pharmacological suppression of the median raphe nucleus with serotonin1A agonists, 8-OH-DPAT and buspirone, produces hippocampal theta rhythm in the rat
352. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: A critical review
353. Genetic association analysis of serotonin system genes in bipolar affective disorder
354. Advances and pathophysiological models of hallucinogenic drug actions in humans: A preamble to schizophrenia research
355. Relapse to cocaine-seeking after hippocampal theta burst stimulation
356. Effects of the 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide in the rat kindling model of epilepsy
357. Differential treatment of bipolar disorder with old and new antiepileptic drugs
358. D(1) dopamine receptors potentiate nmda-mediated excitability increase in layer V prefrontal cortical pyramidal neurons
359. Cross-modulation of synaptic plasticity by beta-adrenergic and 5-HT1A receptors in the rat basolateral amygdala
360. Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry
361. Electrophysiological correlates of presynaptic alpha 2-receptor-mediated inhibition of norepinephrine release at locus coeruleus synapses in dentate gyrus
362. Antikindling effects of locus coeruleus stimulation: Mediation by ascending noradrenergic projections
363. Pharmacology of antidepressants: Selectivity or multiplicity?
364. Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens
365. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group
366. The effects of noradrenergic activation of the nucleus tractus solitarius on memory and in potentiating norepinephrine release in the amygdala
367. The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801. Pharmacol
368. Dopaminergic mechanisms in depression and mania
369. Action of norepinephrine in the dentate gyrus. II. Iontophoretic studies
370. Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration
371. MK-801 (dizocilpine): Synergist and conditioned stimulus in bromocriptine-induced psychomotor sensitization
372. Modulatory actions of norepinephrine in the central nervous system
373. Functional interaction of dopamine and glutamate in the nucleus accumbens in the regulation of locomotion
374. Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder
375. 5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line
376. Three serotonin responses in cultured mouse hippocampal and striatal neurons
377. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations
378. Dopamine enhances terminal excitability of hippocampal-accumbens neurons via D2 receptor: Role of dopamine in presynaptic inhibition
379. Ventral pallidal neuronal responses to dopamine receptor stimulation in the nucleus accumbens
380. Presynaptic involvement of nitric oxide in dopamine D1/D5 receptor-induced sustained enhancement of synaptic currents mediated by ionotropic glutamate receptors in the rat hippocampus
381. Dopamine D1 receptor actions in layers V-VI rat prefrontal cortex neurons in vitro: Modulation of dendritic-somatic signal integration
382. Neuromodulatory action of dopamine in the nucleus accumbens: An in vivo intracellular study
383. Comparison of local and systemic ethanol effects on extracellular dopamine concentration in rat nucleus accumbens by microdialysis
384. Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: A regionally-specific double dissociation
385. The 5-HT3 receptor agonist 2-methyl-5-HT reduces postsynaptic potentials in rat CA1 pyramidal neurons of the hippocampus in vitro
386. Nicotine and heroin augment cocaine-induced dopamine overflow in nucleus accumbens
387. Serotonin3 receptor agonists attenuate glutamate-induced firing in rat hippocampal CA1 pyramidal cells
388. Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine